Clinician Conversations - Improving Genomic Test Interpretation for Real-World Cancer Care

Join this webinar to explore practical strategies for enhancing genomic test interpretation in cancer care, featuring presentations from leading medical directors and oncologists including Sheryl Elkin, PhD, David Barbie, MD, and Andrew Lane, MD, PhD. Learn how to address the significant challenges in interpreting genomic test results for cancer treatment, including variability in turnaround times, reporting standards, and clinical utility that directly impact patient outcomes. Discover the increasingly important role of Molecular Tumor Boards (MTB) in implementing evidence-based precision cancer medicine programs and understand how molecular pathology labs can overcome interpretation challenges to maximize the clinical utility of molecular profiling results. Examine real-world case studies from prestigious institutions like Dana-Farber Cancer Institute and the National Cancer Institute to gain insights into improving test turnaround times, standardizing interpretation processes, and delivering comprehensive, personalized genomic reports that enhance clinical decision-making in oncology practice.